{
  "DOI": "10.1186/s40246-023-00515-2",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-023-00515-2",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eThree and a half years after the pandemic outbreak, now that WHO has formally declared that the emergency is over, COVID-19 is still a significant global issue. Here, we focus on recent developments in genetic and genomic research on COVID-19, and we give an outlook on state-of-the-art therapeutical approaches, as the pandemic is gradually transitioning to an endemic situation. The sequencing and characterization of rare alleles in different populations has made it possible to identify numerous genes that affect either susceptibility to COVID-19 or the severity of the disease. These findings provide a beginning to new avenues and pan-ethnic therapeutic approaches, as well as to potential genetic screening protocols. The causative virus, SARS-CoV-2, is still in the spotlight, but novel threatening virus could appear anywhere at any time. Therefore, continued vigilance and further research is warranted. We also note emphatically that to prevent future pandemics and other world-wide health crises, it is imperative to capitalize on what we have learnt from COVID-19: specifically, regarding its origins, the world’s response, and insufficient preparedness. This requires unprecedented international collaboration and timely data sharing for the coordination of effective response and the rapid implementation of containment measures.\u003c/jats:p\u003e",
  "alternative-id": [
    "515"
  ],
  "article-number": "68",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "8 June 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "16 July 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "24 July 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Biancolella",
      "given": "Michela",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Colona",
      "given": "Vito Luigi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Luzzatto",
      "given": "Lucio",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Watt",
      "given": "Jessica Lee",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Mattiuz",
      "given": "Giorgio",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Conticello",
      "given": "Silvestro G.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kaminski",
      "given": "Naftali",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Mehrian-Shai",
      "given": "Ruty",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ko",
      "given": "Albert I.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gonsalves",
      "given": "Gregg S.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Vasiliou",
      "given": "Vasilis",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Novelli",
      "given": "Giuseppe",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Reichardt",
      "given": "Juergen K. V.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        7,
        24
      ]
    ],
    "date-time": "2023-07-24T14:02:51Z",
    "timestamp": 1690207371000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        7,
        24
      ]
    ],
    "date-time": "2023-07-24T14:06:24Z",
    "timestamp": 1690207584000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        15
      ]
    ],
    "date-time": "2024-04-15T17:55:21Z",
    "timestamp": 1713203721323
  },
  "is-referenced-by-count": 10,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2023,
        7,
        24
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2023,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            7,
            24
          ]
        ],
        "date-time": "2023-07-24T00:00:00Z",
        "timestamp": 1690156800000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            7,
            24
          ]
        ],
        "date-time": "2023-07-24T00:00:00Z",
        "timestamp": 1690156800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00515-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-023-00515-2/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00515-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2023,
        7,
        24
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        7,
        24
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1186/s40246-022-00392-1",
      "author": "M Biancolella",
      "doi-asserted-by": "publisher",
      "first-page": "19",
      "issue": "1",
      "journal-title": "Hum Genomics",
      "key": "515_CR1",
      "unstructured": "Biancolella M, Colona VL, Mehrian-Shai R, Watt JL, Luzzatto L, Novelli G, et al. COVID-19 2022 update: transition of the pandemic to the endemic phase. Hum Genomics. 2022;16(1):19. https://doi.org/10.1186/s40246-022-00392-1.",
      "volume": "16",
      "year": "2022"
    },
    {
      "key": "515_CR2",
      "unstructured": "WHO. World Health Organization. Who.int “who.int”. 2023. Retrieved 04/06, 2023, from “https://www.who.int/news-room/speeches/item/who-director-general-s-opening-remarks-at-the-media-briefing---5-may-2023”."
    },
    {
      "DOI": "10.1038/s41467-023-38435-3",
      "author": "T Tamura",
      "doi-asserted-by": "publisher",
      "first-page": "2800",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "515_CR3",
      "unstructured": "Tamura T, Ito J, Uriu K, Zahradnik J, Kida I, Anraku Y, et al. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants. Nat Commun. 2023;14(1):2800. https://doi.org/10.1038/s41467-023-38435-3.",
      "volume": "14",
      "year": "2023"
    },
    {
      "DOI": "10.1038/s41591-023-02212-y",
      "doi-asserted-by": "publisher",
      "key": "515_CR4",
      "unstructured": "Leung K, Lau EHY, Wong CKH, Leung GM, Wu JT. Estimating the transmission dynamics of SARS-CoV-2 Omicron BF.7 in Beijing after adjustment of the zero-COVID policy in November-December 2022. Nat Med. 2023. https://doi.org/10.1038/s41591-023-02212-y."
    },
    {
      "DOI": "10.1016/j.chom.2022.11.012",
      "doi-asserted-by": "publisher",
      "key": "515_CR5",
      "unstructured": "Qu P, Evans JP, Faraone JN, Zheng YM, Carlin C, Anghelina M, et al. Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2. Cell Host Microbe. 2023;31(1):9–17e3. https://doi.org/10.1016/j.chom.2022.11.012."
    },
    {
      "DOI": "10.46234/ccdcw2021.255",
      "doi-asserted-by": "publisher",
      "key": "515_CR6",
      "unstructured": "Khare S, Gurry C, Freitas L, Schultz MB, Bach G, Diallo A, et al. GISAID's Role in Pandemic Response. China CDC Wkly. 2021;3(49):1049–1051. https://doi.org/10.46234/ccdcw2021.255."
    },
    {
      "DOI": "10.1016/j.chom.2022.11.016",
      "author": "DM Morens",
      "doi-asserted-by": "publisher",
      "first-page": "146",
      "issue": "1",
      "journal-title": "Cell Host Microbe",
      "key": "515_CR7",
      "unstructured": "Morens DM, Taubenberger JK, Fauci AS. Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses. Cell Host Microbe. 2023;31(1):146–57. https://doi.org/10.1016/j.chom.2022.11.016.",
      "volume": "31",
      "year": "2023"
    },
    {
      "DOI": "10.1126/science.abm1208",
      "doi-asserted-by": "publisher",
      "key": "515_CR8",
      "unstructured": "Obermeyer F, Jankowiak M, Barkas N, Schaffner SF, Pyle JD, Yurkovetskiy L, et al. Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness. Science. 2022;376(6599):1327–1332. https://doi.org/10.1126/science.abm1208."
    },
    {
      "DOI": "10.1038/s41579-023-00878-2",
      "author": "PV Markov",
      "doi-asserted-by": "publisher",
      "first-page": "361",
      "issue": "6",
      "journal-title": "Nat Rev Microbiol",
      "key": "515_CR9",
      "unstructured": "Markov PV, Ghafari M, Beer M, Lythgoe K, Simmonds P, Stilianakis NI, et al. The evolution of SARS-CoV-2. Nat Rev Microbiol. 2023;21(6):361–79. https://doi.org/10.1038/s41579-023-00878-2.",
      "volume": "21",
      "year": "2023"
    },
    {
      "DOI": "10.1073/pnas.97.13.6967",
      "author": "A Moya",
      "doi-asserted-by": "publisher",
      "first-page": "6967",
      "issue": "13",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "515_CR10",
      "unstructured": "Moya A, Elena SF, Bracho A, Miralles R, Barrio E. The evolution of RNA viruses: a population genetics view. Proc Natl Acad Sci USA. 2000;97(13):6967–73. https://doi.org/10.1073/pnas.97.13.6967.",
      "volume": "97",
      "year": "2000"
    },
    {
      "DOI": "10.1128/JVI.01031-17",
      "author": "KM Peck",
      "doi-asserted-by": "publisher",
      "first-page": "e01031",
      "issue": "14",
      "journal-title": "J Virol",
      "key": "515_CR11",
      "unstructured": "Peck KM, Lauring AS. Complexities of viral mutation rates. J Virol. 2018;92(14):e01031-e1117. https://doi.org/10.1128/JVI.01031-17.",
      "volume": "92",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.omtn.2023.01.013",
      "doi-asserted-by": "publisher",
      "key": "515_CR12",
      "unstructured": "Chakraborty C, Saha A, Bhattacharya M, Dhama K, Agoramoorthy G. Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants. Mol Ther Nucleic Acids. 2023;31:437–439. https://doi.org/10.1016/j.omtn.2023.01.013."
    },
    {
      "DOI": "10.1038/s41586-020-2895-3",
      "doi-asserted-by": "publisher",
      "key": "515_CR13",
      "unstructured": "Plante JA, Liu Y, Liu J, Xia H, Johnson BA, Lokugamage KG, et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021;592(7852):116–121. https://doi.org/10.1038/s41586-020-2895-3. Erratum in: Nature. 2021 Jul;595(7865):E1"
    },
    {
      "DOI": "10.1038/s41598-021-96950-z",
      "author": "GI López-Cortés",
      "doi-asserted-by": "publisher",
      "first-page": "18847",
      "issue": "1",
      "journal-title": "Sci Rep",
      "key": "515_CR14",
      "unstructured": "López-Cortés GI, Palacios-Pérez M, Zamudio GS, Veledíaz HF, Ortega E, José MV. Neutral evolution test of the spike protein of SARS-CoV-2 and its implications in the binding to ACE2. Sci Rep. 2021;11(1):18847. https://doi.org/10.1038/s41598-021-96950-z.",
      "volume": "11",
      "year": "2021"
    },
    {
      "DOI": "10.1126/scitranslmed.abe2555",
      "doi-asserted-by": "publisher",
      "key": "515_CR15",
      "unstructured": "Popa A, Genger JW, Nicholson MD, Penz T, Schmid D, Aberle SW, et al. Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Sci Transl Med. 2020 Dec 9;12(573):eabe2555. https://doi.org/10.1126/scitranslmed.abe2555. Epub 2020 Nov 23."
    },
    {
      "DOI": "10.1126/science.abg0821",
      "doi-asserted-by": "publisher",
      "key": "515_CR16",
      "unstructured": "Lythgoe KA, Hall M, Ferretti L, de Cesare M, MacIntyre-Cockett G, Trebes A, et al. SARS-CoV-2 within-host diversity and transmission. Science. 2021;372(6539):eabg0821. https://doi.org/10.1126/science.abg0821."
    },
    {
      "DOI": "10.1371/journal.ppat.1009499",
      "author": "AL Valesano",
      "doi-asserted-by": "publisher",
      "first-page": "e1009499",
      "issue": "4",
      "journal-title": "PLoS Pathog",
      "key": "515_CR17",
      "unstructured": "Valesano AL, Rumfelt KE, Dimcheff DE, Blair CN, Fitzsimmons WJ, Petrie JG, et al. Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts. PLoS Pathog. 2021;17(4):e1009499. https://doi.org/10.1371/journal.ppat.1009499.",
      "volume": "17",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.cmi.2020.07.032",
      "author": "A Jary",
      "doi-asserted-by": "publisher",
      "first-page": "1560.e1",
      "issue": "11",
      "journal-title": "Clin Microbiol Infect",
      "key": "515_CR18",
      "unstructured": "Jary A, Leducq V, Malet I, Marot S, Klement-Frutos E, Teyssou E, et al. Evolution of viral quasispecies during SARS-CoV-2 infection. Clin Microbiol Infect. 2020;26(11):1560.e1-1560.e4. https://doi.org/10.1016/j.cmi.2020.07.032.",
      "volume": "26",
      "year": "2020"
    },
    {
      "DOI": "10.1093/ve/veac042",
      "doi-asserted-by": "publisher",
      "key": "515_CR19",
      "unstructured": "Caccuri F, Messali S, Bortolotti D, Di Silvestre D, De Palma A, Cattaneo C, et al. Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host. Virus Evol. 2022;8(1):veac042. https://doi.org/10.1093/ve/veac042."
    },
    {
      "DOI": "10.1016/j.celrep.2021.110205",
      "doi-asserted-by": "publisher",
      "key": "515_CR20",
      "unstructured": "Li J, Du P, Yang L, Zhang J, Song C, Chen D, et al. Two-step fitness selection for intra-host variations in SARS-CoV-2. Cell Rep. 2022;38(2):110205. https://doi.org/10.1016/j.celrep.2021.110205."
    },
    {
      "DOI": "10.1038/s41467-020-19818-2",
      "author": "L van Dorp",
      "doi-asserted-by": "publisher",
      "first-page": "5986",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "515_CR21",
      "unstructured": "van Dorp L, Richard D, Tan CCS, Shaw LP, Acman M, Balloux F. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. Nat Commun. 2020;11(1):5986. https://doi.org/10.1038/s41467-020-19818-2.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.meegid.2020.104351",
      "author": "L van Dorp",
      "doi-asserted-by": "publisher",
      "first-page": "104351",
      "journal-title": "Infect Genet Evol",
      "key": "515_CR22",
      "unstructured": "van Dorp L, Acman M, Richard D, Shaw LP, Ford CE, Ormond L, et al. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect Genet Evol. 2020;83:104351. https://doi.org/10.1016/j.meegid.2020.104351.",
      "volume": "83",
      "year": "2020"
    },
    {
      "DOI": "10.1093/femsre/fuac003",
      "doi-asserted-by": "publisher",
      "key": "515_CR23",
      "unstructured": "Wassenaar TM, Wanchai V, Buzard G, Ussery DW. The first three waves of the Covid-19 pandemic hint at a limited genetic repertoire for SARS-CoV-2. FEMS Microbiol Rev. 2022;46(3):fuac003. https://doi.org/10.1093/femsre/fuac003."
    },
    {
      "DOI": "10.1093/emph/eoac010",
      "author": "M Amicone",
      "doi-asserted-by": "publisher",
      "first-page": "142",
      "issue": "1",
      "journal-title": "Evol Med Public Health",
      "key": "515_CR24",
      "unstructured": "Amicone M, Borges V, Alves MJ, Isidro J, Zé-Zé L, Duarte S, et al. Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution. Evol Med Public Health. 2022;10(1):142–55. https://doi.org/10.1093/emph/eoac010.",
      "volume": "10",
      "year": "2022"
    },
    {
      "DOI": "10.1128/JVI.00694-10",
      "author": "R Sanjuán",
      "doi-asserted-by": "publisher",
      "first-page": "9733",
      "issue": "19",
      "journal-title": "J Virol",
      "key": "515_CR25",
      "unstructured": "Sanjuán R, Nebot MR, Chirico N, Mansky LM, Belshaw R. Viral mutation rates. J Virol. 2010;84(19):9733–48. https://doi.org/10.1128/JVI.00694-10.",
      "volume": "84",
      "year": "2010"
    },
    {
      "DOI": "10.21203/rs.3.rs-1690086/v1",
      "doi-asserted-by": "publisher",
      "key": "515_CR26",
      "unstructured": "Herman C, Bradley C, Gordon A, Wang C, Cooke M, Kohrn B, et al. RNA polymerase inaccuracy underlies SARS-CoV-2 variants and vaccine heterogeneity. Res Sq. 2022. https://doi.org/10.21203/rs.3.rs-1690086/v1."
    },
    {
      "DOI": "10.1073/pnas.0508200103",
      "author": "E Minskaia",
      "doi-asserted-by": "publisher",
      "first-page": "5108",
      "issue": "13",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "515_CR27",
      "unstructured": "Minskaia E, Hertzig T, Gorbalenya AE, Campanacci V, Cambillau C, Canard B, et al. Discovery of an RNA virus 3’-\u003e5’ exoribonuclease that is critically involved in coronavirus RNA synthesis. Proc Natl Acad Sci U S A. 2006;103(13):5108–13. https://doi.org/10.1073/pnas.0508200103.",
      "volume": "103",
      "year": "2006"
    },
    {
      "DOI": "10.1371/journal.ppat.1000896",
      "author": "LD Eckerle",
      "doi-asserted-by": "publisher",
      "first-page": "e1000896",
      "issue": "5",
      "journal-title": "PLoS Pathog",
      "key": "515_CR28",
      "unstructured": "Eckerle LD, Becker MM, Halpin RA, Li K, Venter E, Lu X, et al. Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog. 2010;6(5):e1000896. https://doi.org/10.1371/journal.ppat.1000896.",
      "volume": "6",
      "year": "2010"
    },
    {
      "DOI": "10.1371/journal.ppat.1003565",
      "doi-asserted-by": "publisher",
      "key": "515_CR29",
      "unstructured": "Smith EC, Blanc H, Surdel MC, Vignuzzi M, Denison MR. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics. PLoS Pathog. 2013;9(8):e1003565. https://doi.org/10.1371/journal.ppat.1003565. Erratum in: PLoS Pathog. 2014 Jul;10(7):e1004342. Surdel, Matthew C [added]."
    },
    {
      "DOI": "10.1007/s00018-010-0277-y",
      "author": "Q Kong",
      "doi-asserted-by": "publisher",
      "first-page": "1817",
      "issue": "11",
      "journal-title": "Cell Mol Life Sci",
      "key": "515_CR30",
      "unstructured": "Kong Q, Lin CL. Oxidative damage to RNA: mechanisms, consequences, and diseases. Cell Mol Life Sci. 2010;67(11):1817–29. https://doi.org/10.1007/s00018-010-0277-y.",
      "volume": "67",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.isci.2021.102116",
      "doi-asserted-by": "publisher",
      "key": "515_CR31",
      "unstructured": "Graudenzi A, Maspero D, Angaroni F, Piazza R, Ramazzotti D. Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity. iScience. 2021;24(2):102116. https://doi.org/10.1016/j.isci.2021.102116."
    },
    {
      "DOI": "10.7717/peerj.9648",
      "author": "AY Panchin",
      "doi-asserted-by": "publisher",
      "first-page": "e9648",
      "journal-title": "PeerJ",
      "key": "515_CR32",
      "unstructured": "Panchin AY, Panchin YV. Excessive G-U transversions in novel allele variants in SARS-CoV-2 genomes. PeerJ. 2020;8:e9648. https://doi.org/10.7717/peerj.9648.",
      "volume": "8",
      "year": "2020"
    },
    {
      "DOI": "10.3390/v13030394",
      "author": "C Azgari",
      "doi-asserted-by": "publisher",
      "first-page": "394",
      "issue": "3",
      "journal-title": "Viruses",
      "key": "515_CR33",
      "unstructured": "Azgari C, Kilinc Z, Turhan B, Circi D, Adebali O. The mutation profile of SARS-CoV-2 is primarily shaped by the host antiviral defense. Viruses. 2021;13(3):394. https://doi.org/10.3390/v13030394.",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1126/sciadv.abb5813",
      "doi-asserted-by": "publisher",
      "key": "515_CR34",
      "unstructured": "Di Giorgio S, Martignano F, Torcia MG, Mattiuz G, Conticello SG. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2. Sci Adv. 2020; 17;6(25):eabb5813. https://doi.org/10.1126/sciadv.abb5813."
    },
    {
      "DOI": "10.1128/mSphere.00408-20",
      "doi-asserted-by": "publisher",
      "key": "515_CR35",
      "unstructured": "Simmonds P. Rampant C→U Hypermutation in the genomes of SARS-CoV-2 and other coronaviruses: causes and consequences for their short- and long-term evolutionary trajectories. mSphere. 2020;5(3):e00408–20. https://doi.org/10.1128/mSphere.00408-20."
    },
    {
      "DOI": "10.1007/s13353-022-00688-x",
      "author": "F Martignano",
      "doi-asserted-by": "publisher",
      "first-page": "423",
      "issue": "2",
      "journal-title": "J Appl Genet",
      "key": "515_CR36",
      "unstructured": "Martignano F, Di Giorgio S, Mattiuz G, Conticello SG. Commentary on “poor evidence for host-dependent regular RNA editing in the transcriptome of SARS-CoV-2.” J Appl Genet. 2022;63(2):423–8. https://doi.org/10.1007/s13353-022-00688-x.",
      "volume": "63",
      "year": "2022"
    },
    {
      "DOI": "10.1371/journal.ppat.1009596",
      "author": "P Simmonds",
      "doi-asserted-by": "publisher",
      "first-page": "e1009596",
      "issue": "6",
      "journal-title": "PLoS Pathog",
      "key": "515_CR37",
      "unstructured": "Simmonds P, Ansari MA. Extensive C-\u003eU transition biases in the genomes of a wide range of mammalian RNA viruses; potential associations with transcriptional mutations, damage- or host-mediated editing of viral RNA. PLoS Pathog. 2021;17(6):e1009596. https://doi.org/10.1371/journal.ppat.1009596.",
      "volume": "17",
      "year": "2021"
    },
    {
      "DOI": "10.1098/rspb.2022.1747",
      "doi-asserted-by": "publisher",
      "key": "515_CR38",
      "unstructured": "Zhao L, Hall M, de Cesare M, MacIntyre-Cockett G, Lythgoe K, Fraser C, et al. The mutational spectrum of SARS-CoV-2 genomic and antigenomic RNA. Proc Biol Sci. 2022;289(1987):20221747. https://doi.org/10.1098/rspb.2022.1747"
    },
    {
      "DOI": "10.1038/s41586-022-05189-9",
      "author": "Y Turakhia",
      "doi-asserted-by": "publisher",
      "first-page": "994",
      "issue": "7929",
      "journal-title": "Nature",
      "key": "515_CR39",
      "unstructured": "Turakhia Y, Thornlow B, Hinrichs A, McBroome J, Ayala N, Ye C, Smith K, et al. Pandemic-scale phylogenomics reveals the SARS-CoV-2 recombination landscape. Nature. 2022;609(7929):994–7. https://doi.org/10.1038/s41586-022-05189-9.",
      "volume": "609",
      "year": "2022"
    },
    {
      "DOI": "10.1093/molbev/msac028",
      "doi-asserted-by": "publisher",
      "key": "515_CR40",
      "unstructured": "Ignatieva A, Hein J, Jenkins PA. Ongoing Recombination in SARS-CoV-2 Revealed through Genealogical Reconstruction. Mol Biol Evol. 2022;39(2):msac028. https://doi.org/10.1093/molbev/msac028."
    },
    {
      "DOI": "10.1038/s41598-022-19067-x",
      "author": "K Kim",
      "doi-asserted-by": "publisher",
      "first-page": "14972",
      "issue": "1",
      "journal-title": "Sci Rep",
      "key": "515_CR41",
      "unstructured": "Kim K, Calabrese P, Wang S, Qin C, Rao Y, Feng P, et al. The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness. Sci Rep. 2022;12(1):14972. https://doi.org/10.1038/s41598-022-19067-x.",
      "volume": "12",
      "year": "2022"
    },
    {
      "DOI": "10.1093/nar/gkac1238",
      "author": "Y Nakata",
      "doi-asserted-by": "publisher",
      "first-page": "783",
      "issue": "2",
      "journal-title": "Nucleic Acids Res",
      "key": "515_CR42",
      "unstructured": "Nakata Y, Ode H, Kubota M, Kasahara T, Matsuoka K, Sugimoto A, et al. Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome. Nucleic Acids Res. 2023;51(2):783–95. https://doi.org/10.1093/nar/gkac1238.",
      "volume": "51",
      "year": "2023"
    },
    {
      "DOI": "10.1126/science.abo7896",
      "author": "TN Starr",
      "doi-asserted-by": "publisher",
      "first-page": "420",
      "issue": "6604",
      "journal-title": "Science",
      "key": "515_CR43",
      "unstructured": "Starr TN, Greaney AJ, Hannon WW, Loes AN, Hauser K, Dillen JR, et al. Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution. Science. 2022;377(6604):420–4. https://doi.org/10.1126/science.abo7896.",
      "volume": "377",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41586-022-05644-7",
      "author": "Y Cao",
      "doi-asserted-by": "publisher",
      "first-page": "521",
      "issue": "7948",
      "journal-title": "Nature",
      "key": "515_CR44",
      "unstructured": "Cao Y, Jian F, Wang J, Yu Y, Song W, Yisimayi A, et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature. 2023;614(7948):521–9. https://doi.org/10.1038/s41586-022-05644-7.",
      "volume": "614",
      "year": "2023"
    },
    {
      "DOI": "10.1038/s41467-022-30609-9",
      "author": "U Timilsina",
      "doi-asserted-by": "publisher",
      "first-page": "2935",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "515_CR45",
      "unstructured": "Timilsina U, Umthong S, Ivey EB, Waxman B, Stavrou S. SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5. Nat Commun. 2022;13(1):2935. https://doi.org/10.1038/s41467-022-30609-9.",
      "volume": "13",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.celrep.2021.108761",
      "doi-asserted-by": "publisher",
      "key": "515_CR46",
      "unstructured": "Wu J, Shi Y, Pan X, Wu S, Hou R, Zhang Y, et al. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO. Cell Rep. 2021;34(7):108761. https://doi.org/10.1016/j.celrep.2021.108761."
    },
    {
      "DOI": "10.1093/intimm/dxac044",
      "author": "M Kohyama",
      "doi-asserted-by": "publisher",
      "first-page": "43",
      "issue": "1",
      "journal-title": "Int Immunol",
      "key": "515_CR47",
      "unstructured": "Kohyama M, Suzuki T, Nakai W, Ono C, Matsuoka S, Iwatani K, et al. SARS-CoV-2 ORF8 is a viral cytokine regulating immune responses. Int Immunol. 2023;35(1):43–52. https://doi.org/10.1093/intimm/dxac044.",
      "volume": "35",
      "year": "2023"
    },
    {
      "DOI": "10.1093/ve/veab078",
      "doi-asserted-by": "publisher",
      "key": "515_CR48",
      "unstructured": "Voloch CM, da Silva Francisco R Jr, de Almeida LGP, Brustolini OJ, Cardoso CC, Gerber AL, et al. Intra-host evolution during SARS-CoV-2 prolonged infection. Virus Evol. 2021;7(2):veab078. https://doi.org/10.1093/ve/veab078."
    },
    {
      "DOI": "10.1038/s41591-022-01882-4",
      "author": "S Harari",
      "doi-asserted-by": "publisher",
      "first-page": "1501",
      "issue": "7",
      "journal-title": "Nat Med",
      "key": "515_CR49",
      "unstructured": "Harari S, Tahor M, Rutsinsky N, Meijer S, Miller D, Henig O, et al. Drivers of adaptive evolution during chronic SARS-CoV-2 infections. Nat Med. 2022;28(7):1501–8. https://doi.org/10.1038/s41591-022-01882-4.",
      "volume": "28",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.jgg.2021.12.003",
      "author": "C Wei",
      "doi-asserted-by": "publisher",
      "first-page": "1111",
      "issue": "12",
      "journal-title": "J Genet Genomics",
      "key": "515_CR50",
      "unstructured": "Wei C, Shan KJ, Wang W, Zhang S, Huan Q, Qian W. Evidence for a mouse origin of the SARS-CoV-2 Omicron variant. J Genet Genomics. 2021;48(12):1111–21. https://doi.org/10.1016/j.jgg.2021.12.003.",
      "volume": "48",
      "year": "2021"
    },
    {
      "DOI": "10.1056/NEJMsb2104756",
      "author": "L Corey",
      "doi-asserted-by": "publisher",
      "first-page": "562",
      "issue": "6",
      "journal-title": "N Engl J Med",
      "key": "515_CR51",
      "unstructured": "Corey L, Beyrer C, Cohen MS, Michael NL, Bedford T, Rolland M. SARS-CoV-2 variants in patients with immunosuppression. N Engl J Med. 2021;385(6):562–6. https://doi.org/10.1056/NEJMsb2104756.",
      "volume": "385",
      "year": "2021"
    },
    {
      "DOI": "10.1038/nrg3905",
      "author": "M Sironi",
      "doi-asserted-by": "publisher",
      "first-page": "224",
      "issue": "4",
      "journal-title": "Nat Rev Genet",
      "key": "515_CR52",
      "unstructured": "Sironi M, Cagliani R, Forni D, Clerici M. Evolutionary insights into host-pathogen interactions from mammalian sequence data. Nat Rev Genet. 2015;16(4):224–36. https://doi.org/10.1038/nrg3905.",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.15252/embr.202255393",
      "doi-asserted-by": "publisher",
      "key": "515_CR53",
      "unstructured": "Rochman ND, Wolf YI, Koonin EV. Molecular adaptations during viral epidemics. EMBO Rep. 2022;23(8):e55393. https://doi.org/10.15252/embr.202255393."
    },
    {
      "DOI": "10.3390/genes11091010",
      "author": "A Latini",
      "doi-asserted-by": "publisher",
      "first-page": "1010",
      "issue": "9",
      "journal-title": "Genes",
      "key": "515_CR54",
      "unstructured": "Latini A, Agolini E, Novelli A, Borgiani P, Giannini R, Gravina P, et al. COVID-19 and genetic variants of protein involved in the SARS-CoV-2 entry into the host cells. Genes. 2020;11(9):1010. https://doi.org/10.3390/genes11091010.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.gene.2022.146790",
      "doi-asserted-by": "publisher",
      "key": "515_CR55",
      "unstructured": "Gupta K, Kaur G, Pathak T, Banerjee I. Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity. Gene. 2022;844:146790. https://doi.org/10.1016/j.gene.2022.146790."
    },
    {
      "DOI": "10.1038/s41588-021-01006-7",
      "author": "JE Horowitz",
      "doi-asserted-by": "publisher",
      "first-page": "382",
      "issue": "4",
      "journal-title": "Nat Genet",
      "key": "515_CR56",
      "unstructured": "Horowitz JE, Kosmicki JA, Damask A, Sharma D, Roberts GHL, Justice AE, et al. Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease. Nat Genet. 2022;54(4):382–92. https://doi.org/10.1038/s41588-021-01006-7.",
      "volume": "54",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.ebiom.2022.104390",
      "author": "A Miluzio",
      "doi-asserted-by": "publisher",
      "first-page": "104390",
      "journal-title": "EBioMedicine",
      "key": "515_CR57",
      "unstructured": "Miluzio A, Cuomo A, Cordiglieri C, Donnici L, Pesce E, Bombaci M, et al. Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2. EBioMedicine. 2023;87:104390. https://doi.org/10.1016/j.ebiom.2022.104390.",
      "volume": "87",
      "year": "2023"
    },
    {
      "DOI": "10.1038/s41586-021-03767-x",
      "doi-asserted-by": "publisher",
      "key": "515_CR58",
      "unstructured": "COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature. 2021;600(7889):472–477. https://doi.org/10.1038/s41586-021-03767-x."
    },
    {
      "DOI": "10.1016/j.ebiom.2021.103629",
      "author": "TP Velavan",
      "doi-asserted-by": "publisher",
      "first-page": "103629",
      "journal-title": "EBioMedicine.",
      "key": "515_CR59",
      "unstructured": "Velavan TP, Pallerla SR, Rüter J, Augustin Y, Kremsner PG, Krishna S, et al. Host genetic factors determining COVID-19 susceptibility and severity. EBioMedicine. 2021;72:103629. https://doi.org/10.1016/j.ebiom.2021.103629.",
      "volume": "72",
      "year": "2021"
    },
    {
      "DOI": "10.1093/hmg/ddac158",
      "author": "F Degenhardt",
      "doi-asserted-by": "publisher",
      "first-page": "3945",
      "issue": "23",
      "journal-title": "Hum Mol Genet",
      "key": "515_CR60",
      "unstructured": "Degenhardt F, Ellinghaus D, Juzenas S, Lerga-Jaso J, Wendorff M, Maya-Miles D, et al. Detailed stratified GWAS analysis for severe COVID-19 in four European populations. Hum Mol Genet. 2022;31(23):3945–66. https://doi.org/10.1093/hmg/ddac158.",
      "volume": "31",
      "year": "2022"
    },
    {
      "DOI": "10.1101/2022.12.24.22283874",
      "doi-asserted-by": "publisher",
      "key": "515_CR61",
      "unstructured": "Ganna A. A second update on mapping the human genetic architecture of COVID-19. medRxiv 2022. https://doi.org/10.1101/2022.12.24.22283874."
    },
    {
      "DOI": "10.1007/s10875-021-01071-x",
      "author": "S Ben Shachar",
      "doi-asserted-by": "publisher",
      "first-page": "1154",
      "issue": "6",
      "journal-title": "J Clin Immunol",
      "key": "515_CR62",
      "unstructured": "Ben Shachar S, Barda N, Manor S, Israeli S, Dagan N, Carmi S, et al. MHC Haplotyping of SARS-CoV-2 patients: HLA subtypes are not associated with the presence and severity of COVID-19 in the Israeli population. J Clin Immunol. 2021;41(6):1154–61. https://doi.org/10.1007/s10875-021-01071-x.",
      "volume": "41",
      "year": "2021"
    },
    {
      "DOI": "10.1111/tan.14047",
      "author": "A Novelli",
      "doi-asserted-by": "publisher",
      "first-page": "610",
      "issue": "5",
      "journal-title": "HLA",
      "key": "515_CR63",
      "unstructured": "Novelli A, Andreani M, Biancolella M, Liberatoscioli L, Passarelli C, Colona VL, et al. HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients. HLA. 2020;96(5):610–4. https://doi.org/10.1111/tan.14047.",
      "volume": "96",
      "year": "2020"
    },
    {
      "DOI": "10.4103/1817-1737.185756",
      "doi-asserted-by": "publisher",
      "key": "515_CR64",
      "unstructured": "Hajeer AH, Balkhy H, Johani S, Yousef MZ, Arabi Y. Association of human leukocyte antigen class II alleles with severe Middle East respiratory syndrome-coronavirus infection. Ann Thorac Med. 2016;11(3):211–3. https://doi.org/10.4103/1817-1737.185756."
    },
    {
      "DOI": "10.4414/smw.2020.20248",
      "doi-asserted-by": "publisher",
      "key": "515_CR65",
      "unstructured": "Sanchez-Mazas A. HLA studies in the context of coronavirus outbreaks. Swiss Med Wkly. 2020;150:w20248. https://doi.org/10.4414/smw.2020.20248."
    },
    {
      "DOI": "10.1371/journal.pcbi.1005693",
      "author": "I Alter",
      "doi-asserted-by": "publisher",
      "first-page": "e1005693",
      "issue": "8",
      "journal-title": "PLoS Comput Biol",
      "key": "515_CR66",
      "unstructured": "Alter I, Gragert L, Fingerson S, Maiers M, Louzoun Y. HLA class I haplotype diversity is consistent with selection for frequent existing haplotypes. PLoS Comput Biol. 2017;13(8):e1005693. https://doi.org/10.1371/journal.pcbi.1005693.",
      "volume": "13",
      "year": "2017"
    },
    {
      "DOI": "10.1073/pnas.2208525120.",
      "doi-asserted-by": "publisher",
      "key": "515_CR67",
      "unstructured": "Arshad N, Laurent-Rolle M, Ahmed WS, Hsu JC, Mitchell SM, Pawlak J, et al. SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression. Proc Natl Acad Sci USA. 2023;120(1):e2208525120. https://doi.org/10.1073/pnas.2208525120."
    },
    {
      "DOI": "10.3390/genes14010029",
      "author": "C Dieter",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "issue": "1",
      "journal-title": "Genes",
      "key": "515_CR68",
      "unstructured": "Dieter C, de Almeida BL, Lemos NE, Schaeffer AF, Zanotto C, Ramos DT, et al. Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 genes are associated with worse clinical outcomes in COVID-19. Genes. 2022;14(1):29. https://doi.org/10.3390/genes14010029.",
      "volume": "14",
      "year": "2022"
    },
    {
      "DOI": "10.3390/cells11244096",
      "author": "M Baldassarri",
      "doi-asserted-by": "publisher",
      "first-page": "4096",
      "issue": "24",
      "journal-title": "Cells",
      "key": "515_CR69",
      "unstructured": "Baldassarri M, Zguro K, Tomati V, Pastorino C, Fava F, Croci S, et al. Gain- and loss-of-function CFTR alleles are associated with COVID-19 clinical outcomes. Cells. 2022;11(24):4096. https://doi.org/10.3390/cells11244096.",
      "volume": "11",
      "year": "2022"
    },
    {
      "DOI": "10.1093/hmg/ddac157",
      "author": "L Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "4183",
      "issue": "24",
      "journal-title": "Hum Mol Genet",
      "key": "515_CR70",
      "unstructured": "Zhang L, Sarangi V, Liu D, Ho MF, Grassi AR, Wei L, et al. ACE2 and TMPRSS2 SARS-CoV-2 infectivity genes: deep mutational scanning and characterization of missense variants. Hum Mol Genet. 2022;31(24):4183–92. https://doi.org/10.1093/hmg/ddac157.",
      "volume": "31",
      "year": "2022"
    },
    {
      "DOI": "10.3389/fgene.2022.1073880",
      "author": "P Li",
      "doi-asserted-by": "publisher",
      "first-page": "1073880",
      "issue": "13",
      "journal-title": "Front Genet",
      "key": "515_CR71",
      "unstructured": "Li P, Ke Y, Shen W, Shi S, Wang Y, Lin K, et al. Targeted screening of genetic associations with COVID-19 susceptibility and severity. Front Genet. 2022;30(13):1073880. https://doi.org/10.3389/fgene.2022.1073880.",
      "volume": "30",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41586-022-04447-0",
      "doi-asserted-by": "publisher",
      "key": "515_CR72",
      "unstructured": "Zhang Q, Bastard P, COVID Human Genetic Effort, Cobat A, Casanova JL. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature. 2022;603(7902):587–598. https://doi.org/10.1038/s41586-022-04447-0."
    },
    {
      "DOI": "10.3390/ijms23031716",
      "author": "E Gusev",
      "doi-asserted-by": "publisher",
      "first-page": "1716",
      "issue": "3",
      "journal-title": "Int J Mol Sci",
      "key": "515_CR73",
      "unstructured": "Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS-CoV-2-specific immune response and the pathogenesis of COVID-19. Int J Mol Sci. 2022;23(3):1716. https://doi.org/10.3390/ijms23031716.",
      "volume": "23",
      "year": "2022"
    },
    {
      "DOI": "10.1080/22221751.2020.1780953",
      "author": "CK Yuen",
      "doi-asserted-by": "publisher",
      "first-page": "1418",
      "issue": "1",
      "journal-title": "Emerg Microbes Infect",
      "key": "515_CR74",
      "unstructured": "Yuen CK, Lam JY, Wong WM, Mak LF, Wang X, Chu H, et al. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists. Emerg Microbes Infect. 2020;9(1):1418–28. https://doi.org/10.1080/22221751.2020.1780953.",
      "volume": "9",
      "year": "2020"
    },
    {
      "DOI": "10.1126/science.abo3627",
      "doi-asserted-by": "publisher",
      "key": "515_CR75",
      "unstructured": "Lee D, Le Pen J, Yatim A, Dong B, Aquino Y, Ogishi M, et al. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children. Science. 2023;379(6632):eabo3627. https://doi.org/10.1126/science.abo3627."
    },
    {
      "key": "515_CR76",
      "unstructured": "Matuozzo D, Talouarn E, Marchal A, Manry J, Seeleuthner Y, Zhang Y, et al. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. medRxiv. 2022."
    },
    {
      "DOI": "10.1038/s41467-022-34895-1",
      "author": "N Smith",
      "doi-asserted-by": "publisher",
      "first-page": "7254",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "515_CR77",
      "unstructured": "Smith N, Possémé C, Bondet V, Sugrue J, Townsend L, Charbit B, et al. Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity. Nat Commun. 2022;13(1):7254. https://doi.org/10.1038/s41467-022-34895-1.",
      "volume": "13",
      "year": "2022"
    },
    {
      "DOI": "10.1084/jem.20220170",
      "doi-asserted-by": "publisher",
      "key": "515_CR78",
      "unstructured": "García-García A, Pérez de Diego R, Flores C, Rinchai D, Solé-Violán J, Deyà-Martínez À, et al. Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia. J Exp Med. 2023;220(5):e20220170. https://doi.org/10.1084/jem.20220170."
    },
    {
      "DOI": "10.1056/NEJMoa2209760",
      "author": "G Reis",
      "doi-asserted-by": "publisher",
      "first-page": "518",
      "issue": "6",
      "journal-title": "N Engl J Med",
      "key": "515_CR79",
      "unstructured": "Reis G, Moreira Silva EAS, Medeiros Silva DC, Thabane L, Campos VHS, Ferreira TS, et al. Early treatment with pegylated interferon lambda for Covid-19. N Engl J Med. 2023;388(6):518–28. https://doi.org/10.1056/NEJMoa2209760.",
      "volume": "388",
      "year": "2023"
    },
    {
      "DOI": "10.21203/rs.3.rs-1920034/v1",
      "doi-asserted-by": "crossref",
      "key": "515_CR80",
      "unstructured": "Naushad SM, Mandadapu G, Ramaiah MJ, Almajhdi F, Hussain T. Mechanistic insights into TLR7-mediated clinical outcome in COVID-19 and the potential modulatory role of N-acetylcysteine. Res Square; 2022."
    },
    {
      "DOI": "10.1038/s41586-022-04576-6",
      "author": "A Kousathanas",
      "doi-asserted-by": "publisher",
      "first-page": "97",
      "issue": "7917",
      "journal-title": "Nature",
      "key": "515_CR81",
      "unstructured": "Kousathanas A, Pairo-Castineira E, Rawlik K, Stuckey A, Odhams CA, Walker S, et al. Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature. 2022;607(7917):97–103. https://doi.org/10.1038/s41586-022-04576-6.",
      "volume": "607",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41586-022-05163-5",
      "author": "H Namkoong",
      "doi-asserted-by": "publisher",
      "first-page": "754",
      "issue": "7928",
      "journal-title": "Nature",
      "key": "515_CR82",
      "unstructured": "Namkoong H, Edahiro R, Takano T, Nishihara H, Shirai Y, Sonehara K, et al. DOCK2 is involved in the host genetics and biology of severe COVID-19. Nature. 2022;609(7928):754–60. https://doi.org/10.1038/s41586-022-05163-5.",
      "volume": "609",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.ajhg.2022.10.011",
      "author": "G Jia",
      "doi-asserted-by": "publisher",
      "first-page": "2185",
      "issue": "12",
      "journal-title": "Am J Hum Genet",
      "key": "515_CR83",
      "unstructured": "Jia G, Ping J, Shu X, Yang Y, Cai Q, Kweon SS, et al. Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics. Am J Hum Genet. 2022;109(12):2185–95. https://doi.org/10.1016/j.ajhg.2022.10.011.",
      "volume": "109",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41467-018-08053-5",
      "author": "MA Ferreira",
      "doi-asserted-by": "publisher",
      "first-page": "1741",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "515_CR84",
      "unstructured": "Ferreira MA, Gamazon ER, Al-Ejeh F, Aittomäki K, Andrulis IL, Anton-Culver H, et al. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. Nat Commun. 2019;10(1):1741. https://doi.org/10.1038/s41467-018-08053-5.",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s10038-020-00845-2",
      "author": "Y Momozawa",
      "doi-asserted-by": "publisher",
      "first-page": "11",
      "issue": "1",
      "journal-title": "J Hum Genet",
      "key": "515_CR85",
      "unstructured": "Momozawa Y, Mizukami K. Unique roles of rare variants in the genetics of complex diseases in humans. J Hum Genet. 2021;66(1):11–23. https://doi.org/10.1038/s10038-020-00845-2.",
      "volume": "66",
      "year": "2021"
    },
    {
      "DOI": "10.1126/science.abn8197",
      "doi-asserted-by": "publisher",
      "key": "515_CR86",
      "unstructured": "Gao H, Hamp T, Ede J, Schraiber JG, McRae J, Singer-Berk M, et al. The landscape of tolerated genetic variation in humans and primates. Science. 2023;380(6648):eabn8153. https://doi.org/10.1126/science.abn8197"
    },
    {
      "DOI": "10.1038/s41586-020-03065-y",
      "author": "E Pairo-Castineira",
      "doi-asserted-by": "publisher",
      "first-page": "92",
      "issue": "7848",
      "journal-title": "Nature",
      "key": "515_CR87",
      "unstructured": "Pairo-Castineira E, Clohisey S, Klaric L, Bretherick AD, Rawlik K, Pasko D, et al. Genetic mechanisms of critical illness in COVID-19. Nature. 2021;591(7848):92–8. https://doi.org/10.1038/s41586-020-03065-y.",
      "volume": "591",
      "year": "2021"
    },
    {
      "DOI": "10.1101/2023.01.11.23284427",
      "doi-asserted-by": "crossref",
      "key": "515_CR88",
      "unstructured": "Badla BA, Hanifa MS, Jain R, El Naofal M, Halabi N, Yaslam S, et al. Genetic determinants of severe COVID-19 in young Asian and Middle Eastern patients. medRxiv. 2023."
    },
    {
      "DOI": "10.1038/s41586-022-05542-y",
      "author": "SR Stein",
      "doi-asserted-by": "publisher",
      "first-page": "758",
      "issue": "7941",
      "journal-title": "Nature",
      "key": "515_CR89",
      "unstructured": "Stein SR, Ramelli SC, Grazioli A, Chung JY, Singh M, Yinda CK, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612(7941):758–63. https://doi.org/10.1038/s41586-022-05542-y.",
      "volume": "612",
      "year": "2022"
    },
    {
      "DOI": "10.3389/fimmu.2022.877101",
      "author": "Y Guo",
      "doi-asserted-by": "publisher",
      "first-page": "877101",
      "journal-title": "Front Immunol",
      "key": "515_CR90",
      "unstructured": "Guo Y, Han J, Zhang Y, He J, Yu W, Zhang X, et al. SARS-CoV-2 Omicron variant: epidemiological features, biological characteristics, and clinical significance. Front Immunol. 2022;13:877101. https://doi.org/10.3389/fimmu.2022.877101.",
      "volume": "13",
      "year": "2022"
    },
    {
      "DOI": "10.1126/sciimmunol.abp8966",
      "doi-asserted-by": "publisher",
      "key": "515_CR91",
      "unstructured": "Bastard P, Vazquez S, Liu J, Laurie MT, Wang CY, Gervais A, et al. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs. Sci Immunol. 2022; eabp8966. https://doi.org/10.1126/sciimmunol.abp8966."
    },
    {
      "DOI": "10.1186/s40246-021-00326-3",
      "author": "G Novelli",
      "doi-asserted-by": "publisher",
      "first-page": "27",
      "issue": "1",
      "journal-title": "Hum Genomics",
      "key": "515_CR92",
      "unstructured": "Novelli G, Biancolella M, Mehrian-Shai R, Colona VL, Brito AF, Grubaugh ND, et al. COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy. Hum Genomics. 2021;15(1):27. https://doi.org/10.1186/s40246-021-00326-3.",
      "volume": "15",
      "year": "2021"
    },
    {
      "DOI": "10.15585/mmwr.mm7202a5",
      "doi-asserted-by": "publisher",
      "key": "515_CR93",
      "unstructured": "Hause AM, Marquez P, Zhang B, Su JR, Myers TR, Gee J, et al. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years—United States, October 12-January 1, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(2):39–43. https://doi.org/10.15585/mmwr.mm7202a5."
    },
    {
      "DOI": "10.1038/s41467-023-35815-7",
      "doi-asserted-by": "publisher",
      "key": "515_CR94",
      "unstructured": "Tseng HF, Ackerson BK, Bruxvoort KJ, Sy LS, Tubert JE, Lee GS, et al. Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5. Nat Commun. 2023;14(1):189. https://doi.org/10.1038/s41467-023-35815-7."
    },
    {
      "DOI": "10.1113/EP090802",
      "author": "R Astin",
      "doi-asserted-by": "publisher",
      "first-page": "12",
      "issue": "1",
      "journal-title": "Exp Physiol",
      "key": "515_CR95",
      "unstructured": "Astin R, Banerjee A, Baker MR, Dani M, Ford E, Hull JH, et al. Long COVID: mechanisms, risk factors and recovery. Exp Physiol. 2023;108(1):12–27. https://doi.org/10.1113/EP090802.",
      "volume": "108",
      "year": "2023"
    },
    {
      "DOI": "10.7759/cureus.33421",
      "author": "K Nishi",
      "doi-asserted-by": "publisher",
      "first-page": "e33421",
      "issue": "1",
      "journal-title": "Cureus",
      "key": "515_CR96",
      "unstructured": "Nishi K, Yoshimoto S, Tanaka T, Kimura S, Shinchi Y, Yamano T. A potential novel treatment for chronic cough in long COVID patients: clearance of Epipharyngeal residual SARS-CoV-2 spike RNA by Epipharyngeal abrasive therapy. Cureus. 2023;15(1):e33421. https://doi.org/10.7759/cureus.33421.",
      "volume": "15",
      "year": "2023"
    },
    {
      "DOI": "10.1097/j.pain.0000000000002663",
      "author": "CE Hastie",
      "doi-asserted-by": "publisher",
      "first-page": "84",
      "issue": "1",
      "journal-title": "Pain",
      "key": "515_CR97",
      "unstructured": "Hastie CE, Foster HME, Jani BD, O’Donnell CA, Ho FK, Pell JP, et al. Chronic pain and COVID-19 hospitalisation and mortality: a UK Biobank cohort study. Pain. 2023;164(1):84–90. https://doi.org/10.1097/j.pain.0000000000002663.",
      "volume": "164",
      "year": "2023"
    },
    {
      "DOI": "10.1007/s11916-022-01038-6",
      "author": "K Fiala",
      "doi-asserted-by": "publisher",
      "first-page": "379",
      "issue": "5",
      "journal-title": "Curr Pain Headache Rep",
      "key": "515_CR98",
      "unstructured": "Fiala K, Martens J, Abd-Elsayed A. Post-COVID pain syndromes. Curr Pain Headache Rep. 2022;26(5):379–83. https://doi.org/10.1007/s11916-022-01038-6.",
      "volume": "26",
      "year": "2022"
    },
    {
      "DOI": "10.1097/j.pain.0000000000002718",
      "author": "C Fernández-de-Las-Peñas",
      "doi-asserted-by": "publisher",
      "first-page": "413",
      "issue": "2",
      "journal-title": "Pain",
      "key": "515_CR99",
      "unstructured": "Fernández-de-Las-Peñas C, Cancela-Cilleruelo I, Moro-López-Menchero P, Rodríguez-Jiménez J, Pellicer-Valero OJ, Martín-Guerrero JD, et al. Exploring the trajectory curve of long-term musculoskeletal post-COVID pain symptoms in hospitalized COVID-19 survivors: a multicenter study. Pain. 2023;164(2):413–20. https://doi.org/10.1097/j.pain.0000000000002718.",
      "volume": "164",
      "year": "2023"
    },
    {
      "DOI": "10.1007/s42399-022-01352-5",
      "author": "A Nouraeinejad",
      "doi-asserted-by": "publisher",
      "first-page": "9",
      "issue": "1",
      "journal-title": "SN Compr Clin Med",
      "key": "515_CR100",
      "unstructured": "Nouraeinejad A. Brain fog as a Long-term Sequela of COVID-19. SN Compr Clin Med. 2023;5(1):9. https://doi.org/10.1007/s42399-022-01352-5.",
      "volume": "5",
      "year": "2023"
    },
    {
      "DOI": "10.1016/j.clinph.2022.10.017",
      "author": "V Versace",
      "doi-asserted-by": "publisher",
      "first-page": "81",
      "journal-title": "Clin Neurophysiol",
      "key": "515_CR101",
      "unstructured": "Versace V, Ortelli P, Dezi S, Ferrazzoli D, Alibardi A, Bonini I, et al. Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABAB-ergic activity and cortical plasticity in long COVID-19 syndrome. Clin Neurophysiol. 2023;145:81–8. https://doi.org/10.1016/j.clinph.2022.10.017.",
      "volume": "145",
      "year": "2023"
    },
    {
      "DOI": "10.1016/j.jstrokecerebrovasdis.2022.106904",
      "author": "MJR Lim",
      "doi-asserted-by": "publisher",
      "first-page": "106904",
      "issue": "2",
      "journal-title": "J Stroke Cerebrovasc Dis",
      "key": "515_CR102",
      "unstructured": "Lim MJR, Yeo J, Fong KY, Eng SW, Fu S, Tan BY, et al. Characteristics of subarachnoid hemorrhage associated with COVID-19 infection: a systematic review and descriptive analysis. J Stroke Cerebrovasc Dis. 2023;32(2):106904. https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106904.",
      "volume": "32",
      "year": "2023"
    },
    {
      "key": "515_CR103",
      "unstructured": "COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/. Accessed June 3, 2023."
    },
    {
      "DOI": "10.1016/S2213-2600(22)00528-8",
      "author": "A Amstutz",
      "doi-asserted-by": "publisher",
      "first-page": "453",
      "issue": "5",
      "journal-title": "Lancet Respir Med",
      "key": "515_CR104",
      "unstructured": "Amstutz A, Speich B, Mentré F, Rueegg CS, Belhadi D, Assoumou L, et al. Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials. Lancet Respir Med. 2023;11(5):453–64. https://doi.org/10.1016/S2213-2600(22)00528-8.",
      "volume": "11",
      "year": "2023"
    },
    {
      "DOI": "10.1056/NEJMc2214302",
      "author": "M Imai",
      "doi-asserted-by": "publisher",
      "first-page": "89",
      "issue": "1",
      "journal-title": "N Engl J Med",
      "key": "515_CR105",
      "unstructured": "Imai M, Ito M, Kiso M, Yamayoshi S, Uraki R, Fukushi S, et al. Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB. N Engl J Med. 2023;388(1):89–91. https://doi.org/10.1056/NEJMc2214302.",
      "volume": "388",
      "year": "2023"
    },
    {
      "DOI": "10.1503/cmaj.220471",
      "author": "T Pitre",
      "doi-asserted-by": "publisher",
      "first-page": "E969",
      "issue": "28",
      "journal-title": "CMAJ",
      "key": "515_CR106",
      "unstructured": "Pitre T, Van Alstine R, Chick G, Leung G, Mikhail D, Cusano E, et al. Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis. CMAJ. 2022;194(28):E969–80. https://doi.org/10.1503/cmaj.220471.",
      "volume": "194",
      "year": "2022"
    },
    {
      "DOI": "10.1056/NEJMc2207519",
      "author": "E Takashita",
      "doi-asserted-by": "publisher",
      "first-page": "468",
      "issue": "5",
      "journal-title": "N Engl J Med",
      "key": "515_CR107",
      "unstructured": "Takashita E, Yamayoshi S, Simon V, van Bakel H, Sordillo EM, Pekosz A, et al. Efficacy of antibodies and antiviral drugs against Omicron BA.2.12.1, BA.4, and BA.5 subvariants. N Engl J Med. 2022;387(5):468–70. https://doi.org/10.1056/NEJMc2207519.",
      "volume": "387",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.antiviral.2023.105609",
      "author": "J Cho",
      "doi-asserted-by": "publisher",
      "first-page": "105609",
      "journal-title": "Antiviral Res",
      "key": "515_CR108",
      "unstructured": "Cho J, Shin Y, Yang JS, Kim JW, Kim KC, Lee JY. Evaluation of antiviral drugs against newly emerged SARS-CoV-2 Omicron subvariants. Antiviral Res. 2023;214:105609. https://doi.org/10.1016/j.antiviral.2023.105609.",
      "volume": "214",
      "year": "2023"
    },
    {
      "DOI": "10.7326/M22-0729",
      "author": "MG Johnson",
      "doi-asserted-by": "publisher",
      "first-page": "1126",
      "issue": "8",
      "journal-title": "Placebo-Controlled Trial Ann Intern Med",
      "key": "515_CR109",
      "unstructured": "Johnson MG, Puenpatom A, Moncada PA, Burgess L, Duke ER, Ohmagari N, et al. Effect of molnupiravir on biomarkers, respiratory interventions, and medical services in COVID-19: a randomized. Placebo-Controlled Trial Ann Intern Med. 2022;175(8):1126–34. https://doi.org/10.7326/M22-0729.",
      "volume": "175",
      "year": "2022"
    },
    {
      "DOI": "10.1016/S0140-6736(22)02597-1",
      "author": "CC Butler",
      "doi-asserted-by": "publisher",
      "first-page": "281",
      "issue": "10373",
      "journal-title": "Lancet",
      "key": "515_CR110",
      "unstructured": "Butler CC, Hobbs FDR, Gbinigie OA, Rahman NM, Hayward G, Richards DB, et al. Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial. Lancet. 2023;401(10373):281–93. https://doi.org/10.1016/S0140-6736(22)02597-1.",
      "volume": "401",
      "year": "2023"
    },
    {
      "DOI": "10.1038/s41594-021-00651-0",
      "author": "F Kabinger",
      "doi-asserted-by": "publisher",
      "first-page": "740",
      "issue": "9",
      "journal-title": "Nat Struct Mol Biol",
      "key": "515_CR111",
      "unstructured": "Kabinger F, Stiller C, Schmitzová J, Dienemann C, Kokic G, Hillen HS, et al. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. Nat Struct Mol Biol. 2021;28(9):740–6. https://doi.org/10.1038/s41594-021-00651-0.",
      "volume": "28",
      "year": "2021"
    },
    {
      "DOI": "10.1002/em.22510",
      "author": "JA Miranda",
      "doi-asserted-by": "publisher",
      "first-page": "320",
      "issue": "7",
      "journal-title": "Environ Mol Mutagen",
      "key": "515_CR112",
      "unstructured": "Miranda JA, McKinzie PB, Dobrovolsky VN, Revollo JR. Evaluation of the mutagenic effects of Molnupiravir and N4-hydroxycytidine in bacterial and mammalian cells by HiFi sequencing. Environ Mol Mutagen. 2022;63(7):320–8. https://doi.org/10.1002/em.22510.",
      "volume": "63",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41588-022-01113-z",
      "author": "AR Banday",
      "doi-asserted-by": "publisher",
      "first-page": "1103",
      "issue": "8",
      "journal-title": "Nat Genet",
      "key": "515_CR113",
      "unstructured": "Banday AR, Stanifer ML, Florez-Vargas O, Onabajo OO, Papenberg BW, Zahoor MA, et al. Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries. Nat Genet. 2022;54(8):1103–16. https://doi.org/10.1038/s41588-022-01113-z.",
      "volume": "54",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41586-022-04980-y",
      "author": "Y Cao",
      "doi-asserted-by": "publisher",
      "first-page": "593",
      "issue": "7923",
      "journal-title": "Nature",
      "key": "515_CR114",
      "unstructured": "Cao Y, Yisimayi A, Jian F, Song W, Xiao T, Wang L, et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022;608(7923):593–602. https://doi.org/10.1038/s41586-022-04980-y.",
      "volume": "608",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.cell.2022.12.018",
      "author": "Q Wang",
      "doi-asserted-by": "publisher",
      "first-page": "279",
      "issue": "2",
      "journal-title": "Cell",
      "key": "515_CR115",
      "unstructured": "Wang Q, Iketani S, Li Z, Liu L, Guo Y, Huang Y, et al. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell. 2023;186(2):279-286.e8. https://doi.org/10.1016/j.cell.2022.12.018.",
      "volume": "186",
      "year": "2023"
    },
    {
      "key": "515_CR116",
      "unstructured": "Food and Drug Administration. Fact sheet for health care providers: Emergency Use Authorization (EUA) of COVID-19 convalescent plasma for treatment of coronavirus disease 2019 (COVID-19). 2021. Available at: https://www.fda.gov/media/141478/download."
    },
    {
      "DOI": "10.1056/NEJMoa2021436",
      "doi-asserted-by": "publisher",
      "key": "515_CR117",
      "unstructured": "RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384(8):693–704. https://doi.org/10.1056/NEJMoa2021436."
    },
    {
      "DOI": "10.1016/S0140-6736(23)00510-X",
      "doi-asserted-by": "publisher",
      "key": "515_CR118",
      "unstructured": "RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk; RECOVERY Collaborative Group. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2023;401(10387):1499–1507. https://doi.org/10.1016/S0140-6736(23)00510-X"
    },
    {
      "DOI": "10.1001/jamainternmed.2022.2168",
      "author": "L Bouadma",
      "doi-asserted-by": "publisher",
      "first-page": "906",
      "issue": "9",
      "journal-title": "JAMA Intern Med",
      "key": "515_CR119",
      "unstructured": "Bouadma L, Mekontso-Dessap A, Burdet C, Merdji H, Poissy J, Dupuis C, et al. High-dose dexamethasone and oxygen support strategies in intensive care unit patients with severe COVID-19 acute hypoxemic respiratory failure: the COVIDICUS randomized clinical trial. JAMA Intern Med. 2022;182(9):906–16. https://doi.org/10.1001/jamainternmed.2022.2168.",
      "volume": "182",
      "year": "2022"
    },
    {
      "DOI": "10.1001/jama.2021.18295",
      "doi-asserted-by": "publisher",
      "key": "515_CR120",
      "unstructured": "COVID STEROID 2 Trial Group; Munch MW, Myatra SN, Vijayaraghavan BKT, Saseedharan S, Benfield T, Wahlin RR, et al. Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial. JAMA. 2021;326(18):1807–1817. https://doi.org/10.1001/jama.2021.18295. Erratum in: JAMA. 2021 Dec 14;326(22):2333. Erratum in: JAMA. 2022 Jan 18;327(3):286."
    },
    {
      "DOI": "10.1016/S0140-6736(21)00676-0",
      "author": "RECOVERY Collaborative Group",
      "doi-asserted-by": "publisher",
      "first-page": "1637",
      "issue": "10285",
      "journal-title": "Lancet",
      "key": "515_CR121",
      "unstructured": "RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021;397(10285):1637–45. https://doi.org/10.1016/S0140-6736(21)00676-0.",
      "volume": "397",
      "year": "2021"
    },
    {
      "DOI": "10.1056/NEJMoa2100433",
      "doi-asserted-by": "publisher",
      "key": "515_CR122",
      "unstructured": "REMAP-CAP Investigators; Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, Nichol AD, et al. Interleukin-6 receptor antagonists in critically ill patients with Covid-19. N Engl J Med. 2021;384(16):1491–1502. https://doi.org/10.1056/NEJMoa2100433."
    },
    {
      "DOI": "10.1001/jama.2022.23257",
      "doi-asserted-by": "publisher",
      "key": "515_CR123",
      "unstructured": "Writing Committee for the REMAP-CAP Investigators; Higgins AM, Berry LR, Lorenzi E, Murthy S, McQuilten Z, et al. Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial. JAMA. 2023;329(1):39–51. https://doi.org/10.1001/jama.2022.23257."
    },
    {
      "DOI": "10.1056/NEJMoa2030340",
      "author": "C Salama",
      "doi-asserted-by": "publisher",
      "first-page": "20",
      "issue": "1",
      "journal-title": "N Engl J Med",
      "key": "515_CR124",
      "unstructured": "Salama C, Han J, Yau L, Reiss WG, Kramer B, Neidhart JD, et al. Tocilizumab in patients hospitalized with Covid-19 pneumonia. N Engl J Med. 2021;384(1):20–30. https://doi.org/10.1056/NEJMoa2030340. (7).",
      "volume": "384",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s00134-021-06507-x",
      "author": "IO Rosas",
      "doi-asserted-by": "publisher",
      "first-page": "1258",
      "issue": "11",
      "journal-title": "Intensive Care Med",
      "key": "515_CR125",
      "unstructured": "Rosas IO, Diaz G, Gottlieb RL, Lobo SM, Robinson P, Hunter BD, et al. Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial. Intensive Care Med. 2021;47(11):1258–70. https://doi.org/10.1007/s00134-021-06507-x.",
      "volume": "47",
      "year": "2021"
    },
    {
      "DOI": "10.1016/S0140-6736(22)01109-6.Erratum.In:Lancet.2022Oct1;400(10358):1102",
      "author": "RECOVERY Collaborative Group",
      "doi-asserted-by": "publisher",
      "first-page": "359",
      "issue": "10349",
      "journal-title": "Lancet",
      "key": "515_CR126",
      "unstructured": "RECOVERY Collaborative Group. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Lancet. 2022;400(10349):359–68. https://doi.org/10.1016/S0140-6736(22)01109-6.Erratum.In:Lancet.2022Oct1;400(10358):1102.",
      "volume": "400",
      "year": "2022"
    },
    {
      "DOI": "10.1056/NEJMoa2101643",
      "author": "PO Guimarães",
      "doi-asserted-by": "publisher",
      "first-page": "406",
      "issue": "5",
      "journal-title": "N Engl J Med",
      "key": "515_CR127",
      "unstructured": "Guimarães PO, Quirk D, Furtado RH, Maia LN, Saraiva JF, Antunes MO, et al. Tofacitinib in patients hospitalized with Covid-19 pneumonia. N Engl J Med. 2021;385(5):406–15. https://doi.org/10.1056/NEJMoa2101643.",
      "volume": "385",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.immuni.2020.05.002",
      "author": "N Vabret",
      "doi-asserted-by": "publisher",
      "first-page": "910",
      "issue": "6",
      "journal-title": "Immunity",
      "key": "515_CR128",
      "unstructured": "Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M, et al. Immunology of COVID-19: current state of the science. Immunity. 2020;52(6):910–41. https://doi.org/10.1016/j.immuni.2020.05.002.",
      "volume": "52",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.medj.2020.07.002",
      "author": "J Li",
      "doi-asserted-by": "publisher",
      "first-page": "99",
      "issue": "1",
      "journal-title": "Med (N Y)",
      "key": "515_CR129",
      "unstructured": "Li J, Guo M, Tian X, Wang X, Yang X, Wu P, et al. Virus-host interactome and proteomic survey reveal potential virulence factors influencing SARS-CoV-2 pathogenesis. Med (N Y). 2021;2(1):99-112.e7. https://doi.org/10.1016/j.medj.2020.07.002.",
      "volume": "2",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.lfs.2023.121531",
      "author": "EK Sher",
      "doi-asserted-by": "publisher",
      "first-page": "121531",
      "journal-title": "Life Sci",
      "key": "515_CR130",
      "unstructured": "Sher EK, Ćosović A, Džidić-Krivić A, Farhat EK, Pinjić E, Sher F. Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases. Life Sci. 2023;319:121531. https://doi.org/10.1016/j.lfs.2023.121531.",
      "volume": "319",
      "year": "2023"
    },
    {
      "DOI": "10.3390/jcm11154464",
      "author": "LA Clerbaux",
      "doi-asserted-by": "publisher",
      "first-page": "4464",
      "issue": "15",
      "journal-title": "J Clin Med",
      "key": "515_CR131",
      "unstructured": "Clerbaux LA, Albertini MC, Amigó N, Beronius A, Bezemer GFG, Coecke S, et al. Factors modulating COVID-19: a mechanistic understanding based on the adverse outcome pathway framework. J Clin Med. 2022;11(15):4464. https://doi.org/10.3390/jcm11154464.",
      "volume": "11",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41435-021-00157-1",
      "author": "S Mantovani",
      "doi-asserted-by": "publisher",
      "first-page": "51",
      "issue": "1",
      "journal-title": "Genes Immun",
      "key": "515_CR132",
      "unstructured": "Mantovani S, Daga S, Fallerini C, Baldassarri M, Benetti E, Picchiotti N, et al. Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients. Genes Immun. 2022;23(1):51–6. https://doi.org/10.1038/s41435-021-00157-1.",
      "volume": "23",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41576-021-00408-x",
      "author": "K Tao",
      "doi-asserted-by": "publisher",
      "first-page": "757",
      "issue": "12",
      "journal-title": "Nat Rev Genet",
      "key": "515_CR133",
      "unstructured": "Tao K, Tzou PL, Nouhin J, Gupta RK, de Oliveira T, Kosakovsky Pond SL, et al. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat Rev Genet. 2021;22(12):757–73. https://doi.org/10.1038/s41576-021-00408-x.",
      "volume": "22",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41591-022-01911-2",
      "author": "H Tegally",
      "doi-asserted-by": "publisher",
      "first-page": "1785",
      "issue": "9",
      "journal-title": "Nat Med",
      "key": "515_CR134",
      "unstructured": "Tegally H, Moir M, Everatt J, Giovanetti M, Scheepers C, Wilkinson E, et al. Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa. Nat Med. 2022;28(9):1785–90. https://doi.org/10.1038/s41591-022-01911-2.",
      "volume": "28",
      "year": "2022"
    },
    {
      "DOI": "10.1371/journal.pone.0240146",
      "author": "VME Bridgland",
      "doi-asserted-by": "publisher",
      "first-page": "e0240146",
      "issue": "1",
      "journal-title": "PLoS One.",
      "key": "515_CR135",
      "unstructured": "Bridgland VME, Moeck EK, Green DM, Swain TL, Nayda DM, Matson LA, et al. Why the COVID-19 pandemic is a traumatic stressor. PLoS One. 2021;16(1):e0240146. https://doi.org/10.1371/journal.pone.0240146.",
      "volume": "16",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41562-022-01511-7",
      "author": "S Danielsen",
      "doi-asserted-by": "publisher",
      "journal-title": "Nat Hum Behav",
      "key": "515_CR136",
      "unstructured": "Danielsen S, Joensen A, Andersen PK, Madsen T, Strandberg-Larsen K. Self-injury, suicidality and eating disorder symptoms in young adults following COVID-19 lockdowns in Denmark. Nat Hum Behav. 2023. https://doi.org/10.1038/s41562-022-01511-7.",
      "year": "2023"
    }
  ],
  "reference-count": 136,
  "references-count": 136,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-023-00515-2"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "COVID-19 annual update: a narrative review"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}